Skip to content

Study Assessing the Effectiveness of a Cardiac Web-based eLearning Platform

eEduHeart I: a Multi-center Randomized, Controlled Trial Investigating the Effectiveness of a Cardiac Web-based eLearning Platform

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02475967
Acronym
eEduHeart I
Enrollment
1000
Registered
2015-06-19
Start date
2016-01-31
Completion date
2018-02-28
Last updated
2018-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

E-Learning, coronary artery disease, telerehabilitation, e-health

Brief summary

In the trial cardiac patients will be provided with unrestricted access to the web-based eLearing platform for a one-month period.

Detailed description

Patients participating in the trial will be provided with a cardiac web-based eLearning platform for one month during study period. The medical content of the packages will be gathered from a multidisciplinary input of both medics (e.g. cardiologists) and paramedics (e.g. psychologists). E-Learning packages type I: videos with information from caregivers. In these videos, medics and paramedics are interviewed to highlight the etiology, pathophysiology and treatment of coronary artery disease; the associated comorbidities and the ways to prevent recurrence. E-Learning packages type II: videos in which patients are interviewed. Patients can help each other to adhere to their treatment plan, by sharing stories from their own experience about their illness and the rehabilitation afterwards. Short clips of maximum 2 minutes will be provided to study participants.

Interventions

OTHERIntervention group

The intervention group patients have access to the eLearning platform in addition to conventional cardiac care.The content of platform will be gathered from a multidisciplinary input of both medics (e.g. cardiologists) and paramedics (e.g. psychologists). Patients will also contribute to platform content.

OTHERControl group

The control group patients receive conventional cardiac care alone.

Sponsors

Jessa Hospital
CollaboratorOTHER
Hasselt University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients suffering from coronary artery disease for which they are treated conservatively, with a percutaneous coronary intervention or with coronary artery bypass grafting

Exclusion criteria

* Patients with dementia or cognitive impairment not being able to sufficiently understand the E-Learning packages content * (Foreign) patients unable to speak Dutch, thereby not being able to understand the content of the E-Learning packages * Patients with advanced visual and/or auditory impairments, hindering them to adequately understand the E-earning packages * Patients participating in another trial during the Pilot study period * Patients refusing to provide signed consent

Design outcomes

Primary

MeasureTime frameDescription
Health-related quality of life3 monthsHealth-related quality of life, assessed by HeartQol

Secondary

MeasureTime frameDescription
Adherence to the E-learning packages3 monthsAdherence to the E-learning packages as assessed by the number of logs and the cumulative log time on the E-learning platform per patient.
Effectiveness of E-learning packages3 monthsEffectiveness of intervention in improving patients' knowledge of cardiac diseases as assessed by questionnaire scores.
User experience of eLearning platform3 monthsAsses user experience of eLearning platform by User Experience Questionnaire (UEQ)

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026